(Q34261804)

English

A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans (English)

1 reference

Europe PubMed Central

1 August 2017

author name string

J H Schiller

1

1 reference

Europe PubMed Central

1 August 2017

B Storer

2

1 reference

Europe PubMed Central

1 August 2017

D M Paulnock

3

1 reference

Europe PubMed Central

1 August 2017

R R Brown

4

1 reference

Europe PubMed Central

1 August 2017

S P Datta

5

1 reference

Europe PubMed Central

1 August 2017

P L Witt

6

1 reference

Europe PubMed Central

1 August 2017

E C Borden

7

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 October 1990

1 reference

Europe PubMed Central

1 August 2017

Journal of Clinical Investigation

1 reference

Europe PubMed Central

1 August 2017

86

1 reference

Europe PubMed Central

1 August 2017

1211-1221

1 reference

Europe PubMed Central

1 August 2017

4

1 reference

Europe PubMed Central

1 August 2017

Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

American cancer society Phase I trial of naturally produced beta-interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Phase I evaluation of a synthetic mutant of beta-interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Augmented immunity in cancer patients treated with alpha-interferon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Recombinant interferon-gamma (immuneron): results of a phase I trial in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo beta-interferon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Dependence of the in vitro antiproliferative activity of recombinant human gamma-interferon on the concentration of tryptophan in culture media.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Phase I trial of combinations of recombinant interferons beta(ser) and gamma in patients with advanced malignancy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Phase I study of multiple dose intramuscularly administered recombinant gamma interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Induced proteins in human peripheral mononuclear cells over a range of clinically tolerable doses of interferon-gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 July 2018

Gamma-interferon is one of several direct B cell-maturing lymphokines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296851

28 October 2018

Recombinant interferon-gamma increases HLA-DR synthesis and expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/2120284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2120284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunomodulatory and antiproliferative effect of recombinant alpha, beta, and gamma interferons on cultured human malignant squamous cell lines, SCL-1 and SW-1271

1 reference

https://pubmed.ncbi.nlm.nih.gov/2120284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/2120284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2120284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2120284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/2120284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The determination of tryptophan in plasma, liver, and urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2120284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct and steam distillation autoanalyzer methods for assay of diazotizable aromatic amine metabolites of tryptophan in urine and in serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/2120284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1172/JCI114827

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34261804&oldid=1586929744"